6-bromo-3-(1-methylpyrazol-4-yl)-5-[(3S)-piperidin-3-yl]-N-propan-2-ylpyrazolo[1,5-a]pyridin-7-amine;6-bromo-5-[(3S)-piperidin-3-yl]-3-(1-propan-2-ylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-7-amine;1-[4,5-dimethyl-2-[[(2S)-4-propan-2-ylmorpholin-2-yl]methoxy]phenyl]-3-(5-methylpyrazin-2-yl)urea;3-[3-[4-(3-methylbutyl)phenyl]-1,2-oxazol-5-yl]-5-(4-propan-2-ylsulfonylphenyl)pyrazin-2-amine;N-propan-2-yl-5-(4-propan-2-ylsulfonylphenyl)-3-[3-(4-propylphenyl)-1,2-oxazol-5-yl]pyrazin-2-amine

C114H141Br2N25O9S2 — CID 158765846

IUPAC6-bromo-3-(1-methylpyrazol-4-yl)-5-[(3S)-piperidin-3-yl]-N-propan-2-ylpyrazolo[1,5-a]pyridin-7-amine;6-bromo-5-[(3S)-piperidin-3-yl]-3-(1-propan-2-ylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-7-amine;1-[4,5-dimethyl-2-[[(2S)-4-propan-2-ylmorpholin-2-yl]methoxy]phenyl]-3-(5-methylpyrazin-2-yl)urea;3-[3-[4-(3-methylbutyl)phenyl]-1,2-oxazol-5-yl]-5-(4-propan-2-ylsulfonylphenyl)pyrazin-2-amine;N-propan-2-yl-5-(4-propan-2-ylsulfonylphenyl)-3-[3-(4-propylphenyl)-1,2-oxazol-5-yl]pyrazin-2-amine
SMILESCC(C)CCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)on2)cc1.CC(C)Nc1c(Br)c([C@@H]2CCCNC2)cc2c(-c3cnn(C)c3)cnn12.CC(C)n1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)cc23)cn1.CCCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3NC(C)C)on2)cc1.Cc1cnc(NC(=O)Nc2cc(C)c(C)cc2OC[C@@H]2CN(C(C)C)CCO2)cn1
InChIInChI=1S/C28H32N4O3S.C27H30N4O3S.C22H31N5O3.C19H25BrN6.C18H23BrN6/c1-6-7-20-8-10-21(11-9-20)24-16-26(35-32-24)27-28(30-18(2)3)29-17-25(31-27)22-12-14-23(15-13-22)36(33,34)19(4)5;1-17(2)5-6-19-7-9-20(10-8-19)23-15-25(34-31-23)26-27(28)29-16-24(30-26)21-11-13-22(14-12-21)35(32,33)18(3)4;1-14(2)27-6-7-29-18(12-27)13-30-20-9-16(4)15(3)8-19(20)25-22(28)26-21-11-23-17(5)10-24-21;1-12(2)24-19-18(20)15(13-5-4-6-21-8-13)7-17-16(10-23-26(17)19)14-9-22-25(3)11-14;1-11(2)24-10-13(8-22-24)15-9-23-25-16(15)6-14(17(19)18(25)20)12-4-3-5-21-7-12/h8-19H,6-7H2,1-5H3,(H,29,30);7-18H,5-6H2,1-4H3,(H2,28,29);8-11,14,18H,6-7,12-13H2,1-5H3,(H2,24,25,26,28);7,9-13,21,24H,4-6,8H2,1-3H3;6,8-12,21H,3-5,7,20H2,1-2H3/t;;18-;13-;12-/m..011/s1
InChIKeyIPGCBHPTBRZXOW-SDTOGTDVSA-N
MW2229.49 g/mol
LogP23.15
Rot. Bonds30

About 6-bromo-3-(1-methylpyrazol-4-yl)-5-[(3S)-piperidin-3-yl]-N-propan-2-ylpyrazolo[1,5-a]pyridin-7-amine;6-bromo-5-[(3S)-piperidin-3-yl]-3-(1-propan-2-ylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-7-amine;1-[4,5-dimethyl-2-[[(2S)-4-propan-2-ylmorpholin-2-yl]methoxy]phenyl]-3-(5-methylpyrazin-2-yl)urea;3-[3-[4-(3-methylbutyl)phenyl]-1,2-oxazol-5-yl]-5-(4-propan-2-ylsulfonylphenyl)pyrazin-2-amine;N-propan-2-yl-5-(4-propan-2-ylsulfonylphenyl)-3-[3-(4-propylphenyl)-1,2-oxazol-5-yl]pyrazin-2-amine

6-bromo-3-(1-methylpyrazol-4-yl)-5-[(3S)-piperidin-3-yl]-N-propan-2-ylpyrazolo[1,5-a]pyridin-7-amine;6-bromo-5-[(3S)-piperidin-3-yl]-3-(1-propan-2-ylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-7-amine;1-[4,5-dimethyl-2-[[(2S)-4-propan-2-ylmorpholin-2-yl]methoxy]phenyl]-3-(5-methylpyrazin-2-yl)urea;3-[3-[4-(3-methylbutyl)phenyl]-1,2-oxazol-5-yl]-5-(4-propan-2-ylsulfonylphenyl)pyrazin-2-amine;N-propan-2-yl-5-(4-propan-2-ylsulfonylphenyl)-3-[3-(4-propylphenyl)-1,2-oxazol-5-yl]pyrazin-2-amine (PubChem CID 158765846) has the molecular formula C114H141Br2N25O9S2 and a molecular weight of 2229.49 g/mol. Its IUPAC name is 6-bromo-3-(1-methylpyrazol-4-yl)-5-[(3S)-piperidin-3-yl]-N-propan-2-ylpyrazolo[1,5-a]pyridin-7-amine;6-bromo-5-[(3S)-piperidin-3-yl]-3-(1-propan-2-ylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-7-amine;1-[4,5-dimethyl-2-[[(2S)-4-propan-2-ylmorpholin-2-yl]methoxy]phenyl]-3-(5-methylpyrazin-2-yl)urea;3-[3-[4-(3-methylbutyl)phenyl]-1,2-oxazol-5-yl]-5-(4-propan-2-ylsulfonylphenyl)pyrazin-2-amine;N-propan-2-yl-5-(4-propan-2-ylsulfonylphenyl)-3-[3-(4-propylphenyl)-1,2-oxazol-5-yl]pyrazin-2-amine.

Molecular Properties

Compound Name6-bromo-3-(1-methylpyrazol-4-yl)-5-[(3S)-piperidin-3-yl]-N-propan-2-ylpyrazolo[1,5-a]pyridin-7-amine;6-bromo-5-[(3S)-piperidin-3-yl]-3-(1-propan-2-ylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-7-amine;1-[4,5-dimethyl-2-[[(2S)-4-propan-2-ylmorpholin-2-yl]methoxy]phenyl]-3-(5-methylpyrazin-2-yl)urea;3-[3-[4-(3-methylbutyl)phenyl]-1,2-oxazol-5-yl]-5-(4-propan-2-ylsulfonylphenyl)pyrazin-2-amine;N-propan-2-yl-5-(4-propan-2-ylsulfonylphenyl)-3-[3-(4-propylphenyl)-1,2-oxazol-5-yl]pyrazin-2-amine
PubChem CID158765846
Molecular FormulaC114H141Br2N25O9S2
Molecular Weight2229.49 g/mol
Exact Mass2225.92
IUPAC Name6-bromo-3-(1-methylpyrazol-4-yl)-5-[(3S)-piperidin-3-yl]-N-propan-2-ylpyrazolo[1,5-a]pyridin-7-amine;6-bromo-5-[(3S)-piperidin-3-yl]-3-(1-propan-2-ylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-7-amine;1-[4,5-dimethyl-2-[[(2S)-4-propan-2-ylmorpholin-2-yl]methoxy]phenyl]-3-(5-methylpyrazin-2-yl)urea;3-[3-[4-(3-methylbutyl)phenyl]-1,2-oxazol-5-yl]-5-(4-propan-2-ylsulfonylphenyl)pyrazin-2-amine;N-propan-2-yl-5-(4-propan-2-ylsulfonylphenyl)-3-[3-(4-propylphenyl)-1,2-oxazol-5-yl]pyrazin-2-amine
SMILESCC(C)CCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)on2)cc1.CC(C)Nc1c(Br)c([C@@H]2CCCNC2)cc2c(-c3cnn(C)c3)cnn12.CC(C)n1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)cc23)cn1.CCCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3NC(C)C)on2)cc1.Cc1cnc(NC(=O)Nc2cc(C)c(C)cc2OC[C@@H]2CN(C(C)C)CCO2)cn1
InChIInChI=1S/C28H32N4O3S.C27H30N4O3S.C22H31N5O3.C19H25BrN6.C18H23BrN6/c1-6-7-20-8-10-21(11-9-20)24-16-26(35-32-24)27-28(30-18(2)3)29-17-25(31-27)22-12-14-23(15-13-22)36(33,34)19(4)5;1-17(2)5-6-19-7-9-20(10-8-19)23-15-25(34-31-23)26-27(28)29-16-24(30-26)21-11-13-22(14-12-21)35(32,33)18(3)4;1-14(2)27-6-7-29-18(12-27)13-30-20-9-16(4)15(3)8-19(20)25-22(28)26-21-11-23-17(5)10-24-21;1-12(2)24-19-18(20)15(13-5-4-6-21-8-13)7-17-16(10-23-26(17)19)14-9-22-25(3)11-14;1-11(2)24-10-13(8-22-24)15-9-23-25-16(15)6-14(17(19)18(25)20)12-4-3-5-21-7-12/h8-19H,6-7H2,1-5H3,(H,29,30);7-18H,5-6H2,1-4H3,(H2,28,29);8-11,14,18H,6-7,12-13H2,1-5H3,(H2,24,25,26,28);7,9-13,21,24H,4-6,8H2,1-3H3;6,8-12,21H,3-5,7,20H2,1-2H3/t;;18-;13-;12-/m..011/s1
InChIKeyIPGCBHPTBRZXOW-SDTOGTDVSA-N
XLogP23.15
TPSA430.91 Ų
H-Bond Donors8
H-Bond Acceptors32
Rotatable Bonds30
Heavy Atoms152
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002229.49
LogP ≤ 523.15
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1032

Analyze 6-bromo-3-(1-methylpyrazol-4-yl)-5-[(3S)-piperidin-3-yl]-N-propan-2-ylpyrazolo[1,5-a]pyridin-7-amine;6-bromo-5-[(3S)-piperidin-3-yl]-3-(1-propan-2-ylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-7-amine;1-[4,5-dimethyl-2-[[(2S)-4-propan-2-ylmorpholin-2-yl]methoxy]phenyl]-3-(5-methylpyrazin-2-yl)urea;3-[3-[4-(3-methylbutyl)phenyl]-1,2-oxazol-5-yl]-5-(4-propan-2-ylsulfonylphenyl)pyrazin-2-amine;N-propan-2-yl-5-(4-propan-2-ylsulfonylphenyl)-3-[3-(4-propylphenyl)-1,2-oxazol-5-yl]pyrazin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

6-bromo-3-(1-methylpyrazol-4-yl)-5-[(3R)-piperidin-3-yl]-N-propan-2-ylpyrazolo[1,5-a]pyrimidin-7-amine;6-bromo-5-[(3R)-piperidin-3-yl]-3-(1-propan-2-ylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-7-amine;8-[6-[3-(dimethylamino)propoxy]-3-pyridinyl]-1-(oxan-4-yl)-3-propan-2-ylimidazo[4,5-c]quinolin-2-one;1-[4,5-dimethyl-2-[[(2S)-4-propan-2-ylmorpholin-2-yl]methoxy]phenyl]-3-(5-methylpyrazin-2-yl)urea;3-[3-[4-(3-methylbutyl)phenyl]-1,2-oxazol-5-yl]-5-(4-propan-2-ylsulfonylphenyl)pyrazin-2-amine
CID 157350255
6-bromo-3-(1-methylpyrazol-4-yl)-5-[(3R)-piperidin-3-yl]pyrazolo[1,5-a]pyrimidin-7-amine;1-(6-tert-butyl-2-pyridinyl)-6-[4-(4-methylpiperazin-1-yl)anilino]-2-prop-2-enylpyrazolo[3,4-d]pyrimidin-3-one;8-[6-[3-(dimethylamino)propoxy]-3-pyridinyl]-3-methyl-1-(oxan-4-yl)imidazo[4,5-c]quinolin-2-one;5-ethyl-3-[2-methyl-6-(1H-1,2,4-triazol-5-yl)-3-pyridinyl]-7,8-dihydropyrazino[2,3-b]pyrazin-6-one;methyl-methylidene-[1-[6-[(3R)-3-methylmorpholin-4-yl]-2-(1H-pyrrolo[2,3-b]pyridin-4-yl)pyrimidin-4-yl]cyclopropyl]-oxo-lambda6-sulfane;5-(4-propan-2-ylsulfonylphenyl)-3-[3-(4-propylphenyl)-1,2-oxazol-5-yl]pyrazin-2-amine
CID 157688847
6-bromo-3-(1-methylpyrazol-4-yl)-5-[(3R)-piperidin-3-yl]pyrazolo[1,5-a]pyrimidin-7-amine;1-(6-tert-butyl-2-pyridinyl)-6-[4-(4-methylpiperazin-1-yl)anilino]-2-prop-2-enylpyrazolo[3,4-d]pyrimidin-3-one;8-[6-[3-(dimethylamino)propoxy]-3-pyridinyl]-3-methyl-1-(oxan-4-yl)imidazo[4,5-c]quinolin-2-one;5-ethyl-3-[2-methyl-6-(1H-1,2,4-triazol-5-yl)-3-pyridinyl]-7,8-dihydropyrazino[2,3-b]pyrazin-6-one;methane;methyl-methylidene-[1-[6-[(3R)-3-methylmorpholin-4-yl]-2-(1H-pyrrolo[2,3-b]pyridin-4-yl)pyrimidin-4-yl]cyclopropyl]-oxo-lambda6-sulfane;5-(4-propan-2-ylsulfonylphenyl)-3-[3-(4-propylphenyl)-1,2-oxazol-5-yl]pyrazin-2-amine
CID 159425673
2-N-(2,5-dimethyl-4-piperidin-4-ylphenyl)-4-N-(2-propan-2-ylsulfonylphenyl)pyrazolo[1,5-a][1,3,5]triazine-2,4-diamine;2-N-[2-methoxy-5-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]-4-N-(2-propan-2-ylsulfonylphenyl)pyrazolo[1,5-a][1,3,5]triazine-2,4-diamine;[4-[5-methoxy-2-methyl-4-[[4-(2-propan-2-ylsulfonylanilino)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino]phenyl]piperidin-1-yl]-(1-methylpyrrolidin-2-yl)methanone;2-N-[5-(3-methyl-1,2-oxazol-5-yl)-2-propan-2-yloxyphenyl]-4-N-(2-propan-2-ylsulfonylphenyl)pyrazolo[1,5-a][1,3,5]triazine-2,4-diamine
CID 162088708

Frequently Asked Questions

What is the IUPAC name of 6-bromo-3-(1-methylpyrazol-4-yl)-5-[(3S)-piperidin-3-yl]-N-propan-2-ylpyrazolo[1,5-a]pyridin-7-amine;6-bromo-5-[(3S)-piperidin-3-yl]-3-(1-propan-2-ylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-7-amine;1-[4,5-dimethyl-2-[[(2S)-4-propan-2-ylmorpholin-2-yl]methoxy]phenyl]-3-(5-methylpyrazin-2-yl)urea;3-[3-[4-(3-methylbutyl)phenyl]-1,2-oxazol-5-yl]-5-(4-propan-2-ylsulfonylphenyl)pyrazin-2-amine;N-propan-2-yl-5-(4-propan-2-ylsulfonylphenyl)-3-[3-(4-propylphenyl)-1,2-oxazol-5-yl]pyrazin-2-amine?
The IUPAC name of 6-bromo-3-(1-methylpyrazol-4-yl)-5-[(3S)-piperidin-3-yl]-N-propan-2-ylpyrazolo[1,5-a]pyridin-7-amine;6-bromo-5-[(3S)-piperidin-3-yl]-3-(1-propan-2-ylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-7-amine;1-[4,5-dimethyl-2-[[(2S)-4-propan-2-ylmorpholin-2-yl]methoxy]phenyl]-3-(5-methylpyrazin-2-yl)urea;3-[3-[4-(3-methylbutyl)phenyl]-1,2-oxazol-5-yl]-5-(4-propan-2-ylsulfonylphenyl)pyrazin-2-amine;N-propan-2-yl-5-(4-propan-2-ylsulfonylphenyl)-3-[3-(4-propylphenyl)-1,2-oxazol-5-yl]pyrazin-2-amine (CID 158765846) is 6-bromo-3-(1-methylpyrazol-4-yl)-5-[(3S)-piperidin-3-yl]-N-propan-2-ylpyrazolo[1,5-a]pyridin-7-amine;6-bromo-5-[(3S)-piperidin-3-yl]-3-(1-propan-2-ylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-7-amine;1-[4,5-dimethyl-2-[[(2S)-4-propan-2-ylmorpholin-2-yl]methoxy]phenyl]-3-(5-methylpyrazin-2-yl)urea;3-[3-[4-(3-methylbutyl)phenyl]-1,2-oxazol-5-yl]-5-(4-propan-2-ylsulfonylphenyl)pyrazin-2-amine;N-propan-2-yl-5-(4-propan-2-ylsulfonylphenyl)-3-[3-(4-propylphenyl)-1,2-oxazol-5-yl]pyrazin-2-amine.
What is the SMILES notation for 6-bromo-3-(1-methylpyrazol-4-yl)-5-[(3S)-piperidin-3-yl]-N-propan-2-ylpyrazolo[1,5-a]pyridin-7-amine;6-bromo-5-[(3S)-piperidin-3-yl]-3-(1-propan-2-ylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-7-amine;1-[4,5-dimethyl-2-[[(2S)-4-propan-2-ylmorpholin-2-yl]methoxy]phenyl]-3-(5-methylpyrazin-2-yl)urea;3-[3-[4-(3-methylbutyl)phenyl]-1,2-oxazol-5-yl]-5-(4-propan-2-ylsulfonylphenyl)pyrazin-2-amine;N-propan-2-yl-5-(4-propan-2-ylsulfonylphenyl)-3-[3-(4-propylphenyl)-1,2-oxazol-5-yl]pyrazin-2-amine?
The canonical SMILES for 6-bromo-3-(1-methylpyrazol-4-yl)-5-[(3S)-piperidin-3-yl]-N-propan-2-ylpyrazolo[1,5-a]pyridin-7-amine;6-bromo-5-[(3S)-piperidin-3-yl]-3-(1-propan-2-ylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-7-amine;1-[4,5-dimethyl-2-[[(2S)-4-propan-2-ylmorpholin-2-yl]methoxy]phenyl]-3-(5-methylpyrazin-2-yl)urea;3-[3-[4-(3-methylbutyl)phenyl]-1,2-oxazol-5-yl]-5-(4-propan-2-ylsulfonylphenyl)pyrazin-2-amine;N-propan-2-yl-5-(4-propan-2-ylsulfonylphenyl)-3-[3-(4-propylphenyl)-1,2-oxazol-5-yl]pyrazin-2-amine is CC(C)CCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)on2)cc1.CC(C)Nc1c(Br)c([C@@H]2CCCNC2)cc2c(-c3cnn(C)c3)cnn12.CC(C)n1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)cc23)cn1.CCCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3NC(C)C)on2)cc1.Cc1cnc(NC(=O)Nc2cc(C)c(C)cc2OC[C@@H]2CN(C(C)C)CCO2)cn1.
What is the InChIKey of 6-bromo-3-(1-methylpyrazol-4-yl)-5-[(3S)-piperidin-3-yl]-N-propan-2-ylpyrazolo[1,5-a]pyridin-7-amine;6-bromo-5-[(3S)-piperidin-3-yl]-3-(1-propan-2-ylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-7-amine;1-[4,5-dimethyl-2-[[(2S)-4-propan-2-ylmorpholin-2-yl]methoxy]phenyl]-3-(5-methylpyrazin-2-yl)urea;3-[3-[4-(3-methylbutyl)phenyl]-1,2-oxazol-5-yl]-5-(4-propan-2-ylsulfonylphenyl)pyrazin-2-amine;N-propan-2-yl-5-(4-propan-2-ylsulfonylphenyl)-3-[3-(4-propylphenyl)-1,2-oxazol-5-yl]pyrazin-2-amine?
The InChIKey is IPGCBHPTBRZXOW-SDTOGTDVSA-N. The full InChI is InChI=1S/C28H32N4O3S.C27H30N4O3S.C22H31N5O3.C19H25BrN6.C18H23BrN6/c1-6-7-20-8-10-21(11-9-20)24-16-26(35-32-24)27-28(30-18(2)3)29-17-25(31-27)22-12-14-23(15-13-22)36(33,34)19(4)5;1-17(2)5-6-19-7-9-20(10-8-19)23-15-25(34-31-23)26-27(28)29-16-24(30-26)21-11-13-22(14-12-21)35(32,33)18(3)4;1-14(2)27-6-7-29-18(12-27)13-30-20-9-16(4)15(3)8-19(20)25-22(28)26-21-11-23-17(5)10-24-21;1-12(2)24-19-18(20)15(13-5-4-6-21-8-13)7-17-16(10-23-26(17)19)14-9-22-25(3)11-14;1-11(2)24-10-13(8-22-24)15-9-23-25-16(15)6-14(17(19)18(25)20)12-4-3-5-21-7-12/h8-19H,6-7H2,1-5H3,(H,29,30);7-18H,5-6H2,1-4H3,(H2,28,29);8-11,14,18H,6-7,12-13H2,1-5H3,(H2,24,25,26,28);7,9-13,21,24H,4-6,8H2,1-3H3;6,8-12,21H,3-5,7,20H2,1-2H3/t;;18-;13-;12-/m..011/s1.
What are the key properties of 6-bromo-3-(1-methylpyrazol-4-yl)-5-[(3S)-piperidin-3-yl]-N-propan-2-ylpyrazolo[1,5-a]pyridin-7-amine;6-bromo-5-[(3S)-piperidin-3-yl]-3-(1-propan-2-ylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-7-amine;1-[4,5-dimethyl-2-[[(2S)-4-propan-2-ylmorpholin-2-yl]methoxy]phenyl]-3-(5-methylpyrazin-2-yl)urea;3-[3-[4-(3-methylbutyl)phenyl]-1,2-oxazol-5-yl]-5-(4-propan-2-ylsulfonylphenyl)pyrazin-2-amine;N-propan-2-yl-5-(4-propan-2-ylsulfonylphenyl)-3-[3-(4-propylphenyl)-1,2-oxazol-5-yl]pyrazin-2-amine?
6-bromo-3-(1-methylpyrazol-4-yl)-5-[(3S)-piperidin-3-yl]-N-propan-2-ylpyrazolo[1,5-a]pyridin-7-amine;6-bromo-5-[(3S)-piperidin-3-yl]-3-(1-propan-2-ylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-7-amine;1-[4,5-dimethyl-2-[[(2S)-4-propan-2-ylmorpholin-2-yl]methoxy]phenyl]-3-(5-methylpyrazin-2-yl)urea;3-[3-[4-(3-methylbutyl)phenyl]-1,2-oxazol-5-yl]-5-(4-propan-2-ylsulfonylphenyl)pyrazin-2-amine;N-propan-2-yl-5-(4-propan-2-ylsulfonylphenyl)-3-[3-(4-propylphenyl)-1,2-oxazol-5-yl]pyrazin-2-amine has a molecular weight of 2229.49 g/mol, XLogP of 23.15, 30 rotatable bonds, 8 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for 6-bromo-3-(1-methylpyrazol-4-yl)-5-[(3S)-piperidin-3-yl]-N-propan-2-ylpyrazolo[1,5-a]pyridin-7-amine;6-bromo-5-[(3S)-piperidin-3-yl]-3-(1-propan-2-ylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-7-amine;1-[4,5-dimethyl-2-[[(2S)-4-propan-2-ylmorpholin-2-yl]methoxy]phenyl]-3-(5-methylpyrazin-2-yl)urea;3-[3-[4-(3-methylbutyl)phenyl]-1,2-oxazol-5-yl]-5-(4-propan-2-ylsulfonylphenyl)pyrazin-2-amine;N-propan-2-yl-5-(4-propan-2-ylsulfonylphenyl)-3-[3-(4-propylphenyl)-1,2-oxazol-5-yl]pyrazin-2-amine is sourced from PubChem (CID 158765846), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).